TrianglePUBLICATIONS · 23262204
Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Gynecol Oncol
- Publication date
- 2013 Apr
- First author
- Alvarez EA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Alvarez EA
- type
- Author
- name
- Brady WE
- type
- Author
- name
- Walker JL
- type
- Author
- name
- Rotmensch J
- type
- Author
- name
- Zhou XC
- type
- Author
- name
- Kendrick JE
- type
- Author
- name
- Yamada SD
- type
- Author
- name
- Schilder JM
- type
- Author
- name
- Cohn DE
- type
- Author
- name
- Harrison CR
- type
- Author
- name
- Moore KN
- type
- Author
- name
- Aghajanian C
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Alvarez EA
- type
- Author
- name
- Brady WE
- type
- Author
- name
- Walker JL
- type
- Author
- name
- Rotmensch J
- type
- Author
- name
- Zhou XC
- type
- Author
- name
- Kendrick JE
- type
- Author
- name
- Yamada SD
- type
- Author
- name
- Schilder JM
- type
- Author
- name
- Cohn DE
- type
- Author
- name
- Harrison CR
- type
- Author
- name
- Moore KN
- type
- Author
- name
- Aghajanian C
- type
- Author
- bibliography ids
- nci-bib-1fdbfd64bc1d1077df043fa0
- book metadata
- content sha256
- 5df067dea00fcb01f011a94c8d4d439d591c37cea0014ea4423fa9b113d3e162
- document type
- citation
- dois
- 10.1016/j.ygyno.2012.12.022
- electronic publication date
- display
- 2012 Dec 20
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23262204
- immutable id
- pubmed:23262204@5df067dea00fcb01f011a94c8d4d439d591c37cea0014ea4423fa9b113d3e162
- journal
- abbreviation
- Gynecol Oncol
- issn electronic
- 1095-6859
- issn print
- 0090-8258
- issue
- 1
- name
- Gynecologic oncology
- nlm unique id
- 0365304
- pages
- 22-7
- volume
- 129
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23262204
- provenance
- batch id
- 99e85dbb34a1a3011c9a
- provider
- NCBI PubMed ESummary
- record sha256
- df19876c3225164fcc5d25ec73d43074952eeac5c9d35a2e7a64e65995e9b92c
- response sha256
- 1f4a46dcee9da36f8f58fe356dce3f44a1b3004f404e9fb0184f4e08aed4acf2
- retrieved at
- 2026-09-09T23:46:52.860383+00:00
- publication date
- display
- 2013 Apr
- precision
- month
- year
- 2013
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study.
Preserved source evidence · Not medical advice